GO:0060982 coronary artery morphogenesis: Developmental Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060982 coronary artery morphogenesis describes the developmental process that generates and organizes the anatomical structures of coronary arteries, the vessels that supply blood to the heart muscle.
• Coronary arteries arise from multiple progenitor sources, including sinus venosus endocardium, epicardium-derived cells, and endocardial cells, which migrate and differentiate into arterial endothelium and smooth muscle.
• Key molecular regulators include SOX17, which drives coronary arteriogenesis, and PIEZO1, which mediates mechanotransduction in vessel remodeling.
• Disruptions in coronary artery morphogenesis cause congenital coronary anomalies, which can lead to myocardial ischemia, heart failure, and sudden cardiac death.
• Emerging evidence links coronary artery morphogenesis to de novo collateral formation after cardiac injury, involving sprouting tip cells and arterialization programs.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of genes such as SOX17, PIEZO1, and BAF200 in coronary artery development.
Description
Coronary artery morphogenesis (GO:0060982) is the biological process that generates and organizes the anatomical structures of coronary arteries, the blood vessels responsible for transporting blood to the heart muscle. This process is essential for establishing a functional coronary circulation during embryonic development and for maintaining cardiac homeostasis throughout life. Defects in coronary artery morphogenesis are associated with congenital coronary anomalies, which can cause myocardial ischemia and sudden cardiac death. Understanding the cellular and molecular mechanisms underlying this process is therefore critical for developmental biology, regenerative medicine, and cardiovascular disease research. Recent studies have identified diverse progenitor populations and signaling pathways that orchestrate coronary artery formation, including epicardium-derived cells, sinus venosus endocardium, and key transcriptional regulators such as SOX17. Moreover, mechanosensitive channels like PIEZO1 have been implicated in vessel remodeling and arteriogenesis, highlighting the interplay between genetic programs and hemodynamic forces. This article synthesizes current knowledge on coronary artery morphogenesis, its regulatory mechanisms, associated diseases, and the research methods used to study it, with a focus on CRISPR-based approaches for functional genomics.
coronary artery morphogenesis At A Glance
| GO ID | GO:0060982 |
|---|---|
| GO term | coronary artery morphogenesis |
| Ontology | biological_process |
| Synonym | none |
| Major function | Generation and organization of coronary artery anatomical structures to supply blood to heart muscle |
| Key cell types | Endothelial cells, smooth muscle cells, pericytes, epicardium-derived cells |
| Major regulators | SOX17, PIEZO1, BAF200, sprouting tip cells |
| Associated diseases | Congenital coronary anomalies, myocardial ischemia, heart failure |
| Research methods | Lineage tracing, CRISPR knockout, knock-in reporters, imaging, single-cell RNA-seq |
What Is GO:0060982?
GO:0060982 coronary artery morphogenesis is defined as the process in which the anatomical structures of coronary arteries are generated and organized. Coronary arteries are blood vessels that transport blood to the heart muscle. This process encompasses the specification, migration, differentiation, and assembly of endothelial and mural cells into functional arterial networks, as well as the remodeling events that establish coronary artery patterning.
Why Is coronary artery morphogenesis Important in Cell Biology?
Coronary artery morphogenesis is fundamental to heart development and function because coronary arteries are the sole vessels that supply oxygenated blood to the myocardium. Disruptions in this process lead to congenital coronary anomalies, which are clinically significant causes of myocardial ischemia, arrhythmias, and sudden cardiac death, particularly in young individuals. Understanding the molecular and cellular mechanisms of coronary artery morphogenesis is therefore essential for developing diagnostic markers and therapeutic strategies for congenital heart disease and ischemic heart disease. Furthermore, insights into coronary artery development inform regenerative approaches aimed at promoting collateral vessel formation after myocardial infarction.
• Coronary artery morphogenesis is essential for establishing the coronary circulation that supplies oxygen and nutrients to the heart muscle.
• Defects in coronary artery morphogenesis cause congenital coronary anomalies, which can lead to myocardial ischemia and sudden cardiac death.
• Multiple progenitor cell populations, including sinus venosus endocardium and epicardium-derived cells, contribute to coronary artery formation.
• SOX17 is a critical transcriptional regulator of coronary arteriogenesis, and its dysfunction impairs arterial development.
• PIEZO1-mediated mechanotransduction influences vessel remodeling and arteriogenesis in response to hemodynamic forces.
• Sprouting tip cells specify coronary arterialization, providing targets for therapeutic angiogenesis.
• De novo coronary collateral formation after cardiac injury shares molecular programs with developmental coronary artery morphogenesis.
• BAF200 (ARID2) is required for heart morphogenesis and coronary artery development, linking chromatin remodeling to coronary vessel formation.
• Understanding coronary artery morphogenesis aids in engineering vascularized cardiac tissues for regenerative medicine.
• CRISPR-based functional screens can identify novel regulators of coronary artery morphogenesis, accelerating target discovery.
What Happens During coronary artery morphogenesis?
Specification of coronary progenitor cells
In simple terms: The heart starts by setting aside special cells that will become coronary arteries.
Coronary artery morphogenesis begins with the specification of progenitor cells from multiple sources, including the sinus venosus endocardium, epicardium, and endocardial cells. These progenitors are instructed by signaling molecules such as VEGF and Notch ligands to adopt an arterial endothelial fate. Lineage tracing studies in mice have shown that sinus venosus endocardial cells migrate into the heart and form the majority of coronary endothelial cells. Epicardium-derived cells contribute to smooth muscle and pericyte populations that stabilize the nascent vessels.
Migration and sprouting of endothelial cells
In simple terms: The specified cells move and sprout to form the first primitive coronary vessels.
After specification, endothelial progenitors migrate and sprout to form a primary vascular plexus. Sprouting tip cells, characterized by high expression of Dll4 and CXCR4, lead the migration and specify arterialization. These tip cells extend filopodia and respond to guidance cues such as Sema3E and Netrin1. The process is tightly regulated by VEGF-A gradients and Notch signaling, which balance tip and stalk cell fates. In mice, genetic ablation of tip cells impairs coronary arterialization and leads to defective coronary artery patterning.
Arterialization and smooth muscle recruitment
In simple terms: The primitive vessels mature into arteries by recruiting smooth muscle cells and turning on arterial genes.
Arterialization involves the differentiation of endothelial cells into arterial endothelium and the recruitment of smooth muscle cells and pericytes. SOX17 is a key transcription factor that promotes coronary arteriogenesis by activating arterial-specific genes such as Notch1 and Hey2. Loss of Sox17 in mice results in defective coronary artery development and impaired arterialization. Epicardium-derived cells migrate into the vessel wall and differentiate into smooth muscle cells under the control of PDGF-B and TGF-beta signaling.
Remodeling and stabilization of coronary arteries
In simple terms: The vessels are reshaped and stabilized to form mature coronary arteries.
Once the initial arterial network is formed, remodeling events refine the vascular pattern and stabilize the vessels. PIEZO1, a mechanosensitive ion channel, senses blood flow-induced shear stress and promotes vessel remodeling and arteriogenesis. In vein graft models, PIEZO1 activation enhances donor lymphatic remodeling and integrates with autologous lymphangiogenesis to improve graft patency. Similarly, in coronary artery morphogenesis, hemodynamic forces influence endothelial cell alignment and smooth muscle coverage. BAF200 (ARID2), a subunit of the SWI/SNF chromatin remodeling complex, is required for heart morphogenesis and coronary artery development, likely by regulating gene expression programs essential for vessel stabilization.
Formation of coronary collateral circulation
In simple terms: The heart can grow new collateral vessels after injury, using similar programs to development.
In addition to developmental coronary artery morphogenesis, the heart can form de novo coronary collaterals after injury. Recent lineage tracing studies in mice have shown that de novo coronary collateral formation after cardiac repair involves progenitor cells that share molecular signatures with developmental coronary artery morphogenesis. These collaterals can restore blood flow to ischemic myocardium, and understanding their origins may inform therapeutic strategies to promote collateral growth in patients with coronary artery disease.
Key Genes Involved in GO:0060982 coronary artery morphogenesis
The following genes and proteins have been experimentally implicated in coronary artery morphogenesis, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SOX17 | Transcription factor driving coronary arteriogenesis and arterial gene expression | Knockout in mice causes defective coronary artery development; target for arteriogenesis studies |
| PIEZO1 | Mechanosensitive ion channel mediating shear stress responses and vessel remodeling | Implicated in vein graft remodeling and arteriogenesis; potential target for enhancing collateral growth |
| ARID2 (BAF200) | Chromatin remodeling subunit required for heart morphogenesis and coronary artery development | Knockout leads to coronary artery defects; links epigenetics to coronary vessel formation |
| VEGFA | Secreted growth factor promoting endothelial migration and sprouting | Essential for coronary plexus formation; used in angiogenesis assays |
| NOTCH1 | Receptor regulating arterial endothelial fate and tip/stalk cell specification | Modulates coronary arterialization; target for Notch signaling studies |
| DLL4 | Notch ligand marking sprouting tip cells | Tip cell marker for coronary arterialization; used in lineage tracing |
| CXCR4 | Chemokine receptor guiding endothelial tip cell migration | Expressed in sprouting tip cells; involved in coronary artery patterning |
| PDGFB | Growth factor recruiting smooth muscle cells to nascent arteries | Promotes mural cell investment; knockout impairs coronary artery stability |
| TGFB1 | Cytokine regulating smooth muscle differentiation and vessel maturation | Epicardium-derived smooth muscle differentiation; target for fibrosis studies |
| HEY2 | Notch target gene promoting arterial endothelial identity | Downstream of SOX17; marker of arterialization |
| NRP1 | Co-receptor for VEGF and semaphorin signaling | Regulates coronary artery patterning; knockout causes vascular defects |
| SEMA3E | Guidance cue for endothelial tip cells | Modulates coronary artery sprouting; involved in arterial patterning |
| NETRIN1 | Axon guidance molecule with vascular roles | Regulates coronary artery morphogenesis; potential therapeutic target |
| FLT1 (VEGFR1) | Decoy receptor modulating VEGF signaling | Fine-tunes coronary angiogenesis; knockout leads to vascular overgrowth |
| KDR (VEGFR2) | Primary VEGF receptor mediating endothelial proliferation and migration | Essential for coronary artery development; target for inhibitor studies |
| CDH5 (VE-cadherin) | Endothelial adherens junction protein | Maintains endothelial barrier during coronary morphogenesis; used in lineage tracing |
| ACTA2 | Smooth muscle actin marking differentiated mural cells | Marker of coronary artery smooth muscle; used in immunofluorescence |
| MYH11 | Smooth muscle myosin heavy chain | Marker of mature coronary artery smooth muscle cells |
How Is coronary artery morphogenesis Regulated?
Coronary artery morphogenesis is regulated by a combination of transcriptional, signaling, and mechanical cues. SOX17 acts as a master transcriptional regulator of coronary arteriogenesis by activating arterial genes such as NOTCH1 and HEY2. VEGF-A gradients and Notch signaling control endothelial tip and stalk cell specification during sprouting. Hemodynamic forces sensed by PIEZO1 modulate vessel remodeling and arteriogenesis, linking mechanical stimuli to gene expression. Chromatin remodeling complexes, including the BAF complex subunit BAF200 (ARID2), are required for heart morphogenesis and coronary artery development, suggesting epigenetic regulation of coronary gene programs. Additionally, epicardium-derived cells provide paracrine signals such as PDGF-B and TGF-beta that regulate smooth muscle recruitment and vessel stabilization.
coronary artery morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SOX17 | Congenital coronary anomalies, impaired arteriogenesis | Sox17 knockout mouse; coronary endothelial-specific deletion |
| PIEZO1 | Vascular remodeling defects, vein graft failure | Piezo1 knockout mouse; vein graft model |
| ARID2 (BAF200) | Heart morphogenesis defects, coronary artery anomalies | Arid2 knockout mouse; conditional cardiac deletion |
| VEGFA | Impaired coronary angiogenesis, myocardial ischemia | Vegfa conditional knockout; hypoxia models |
| NOTCH1 | Defective arterial specification, coronary anomalies | Notch1 knockout; endothelial-specific deletion |
Congenital coronary artery anomalies
Defects in coronary artery morphogenesis cause congenital coronary anomalies, which include anomalous origin, course, and termination of coronary arteries. These anomalies can lead to myocardial ischemia, arrhythmias, and sudden cardiac death, particularly in young athletes. The morphogenesis of abnormal coronary arteries in congenitally malformed hearts has been studied extensively, revealing that altered developmental programs contribute to these defects. Understanding the genetic and cellular basis of coronary artery morphogenesis is essential for diagnosing and managing these conditions.
Coronary artery disease and collateral formation
Impaired coronary artery morphogenesis or collateral formation contributes to coronary artery disease (CAD) and myocardial infarction. De novo coronary collateral formation after cardiac injury can restore blood flow to ischemic myocardium, and recent studies have traced the origins of these collaterals to progenitor cells that share developmental programs with coronary artery morphogenesis. Enhancing collateral growth is a therapeutic goal for CAD, and insights into developmental mechanisms may inform new strategies.
Heart failure and myocardial ischemia
Defective coronary artery development can result in insufficient myocardial perfusion, leading to heart failure and myocardial ischemia. SOX17 dysfunction impairs coronary arteriogenesis and has been linked to impaired cardiac function in animal models. PIEZO1-mediated mechanotransduction is critical for vessel remodeling, and its dysregulation may contribute to vascular pathologies. Thus, genes involved in coronary artery morphogenesis are potential therapeutic targets for ischemic heart disease.
From coronary artery morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SOX17 impair coronary arteriogenesis? | SOX17 knockout mouse or endothelial-specific conditional knockout |
| Does PIEZO1 mediate shear stress-induced coronary remodeling? | PIEZO1 knockout mouse and vein graft remodeling model |
| What is the role of BAF200 in coronary artery development? | BAF200 (ARID2) knockout mouse with cardiac phenotyping |
| Can overexpression of VEGF-A enhance coronary collateral formation? | VEGF-A overexpression mouse model or AAV-mediated gene delivery |
| What is the lineage of coronary collateral-forming cells? | Inducible Cre lineage tracing in mice |
| Does a point mutation in NOTCH1 alter coronary arterialization? | Notch1 point-mutation knock-in mouse |
How to Study the coronary artery morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lineage tracing (Cre-loxP) | Progenitor contribution to coronary arteries | Identifying cellular origins of coronary endothelium and smooth muscle |
| Single-cell RNA-seq | Transcriptomic profiles of coronary cell populations | Discovering regulators of arterialization and tip cell specification |
| Confocal/light-sheet microscopy | 3D architecture of coronary vessels | Quantifying vessel density and arterial coverage in mutants |
| CRISPR knockout screens | Gene function in endothelial sprouting | Identifying novel regulators of coronary artery morphogenesis |
| Immunofluorescence | Protein expression and localization | Validating SOX17, PIEZO1, and smooth muscle markers |
| In situ hybridization | mRNA expression patterns | Mapping gene expression during coronary development |
| Flow cytometry | Cell surface marker profiles | Isolating coronary endothelial and mural cells |
| Bioinformatics pathway analysis | Enriched gene sets and networks | Interpreting omics data from coronary development studies |
Lineage tracing and genetic fate mapping
Lineage tracing using Cre-loxP systems in mice has been instrumental in identifying the progenitor sources of coronary arteries, including sinus venosus endocardium and epicardium. Inducible Cre lines driven by endothelial or epicardial promoters allow temporal control of labeling. These methods have revealed that coronary collateral-forming cells share developmental origins with embryonic coronary arteries.
Single-cell RNA sequencing
Single-cell RNA sequencing (scRNA-seq) enables unbiased profiling of coronary endothelial and mural cell populations during development. This approach has identified distinct subtypes of tip cells and arterial endothelial cells, as well as transcriptional regulators such as SOX17. scRNA-seq can also reveal heterogeneity in coronary progenitor cells and their differentiation trajectories.
Imaging and morphometrics
Confocal and light-sheet microscopy of whole-mount hearts stained with endothelial and smooth muscle markers allow three-dimensional reconstruction of coronary artery networks. Morphometric analyses quantify vessel density, branching, and arterial coverage. These methods are essential for assessing phenotypes in knockout and knock-in models.
CRISPR-based functional screens
CRISPR knockout screens in endothelial cells or mouse models can identify novel regulators of coronary artery morphogenesis. Pooled sgRNA libraries targeting chromatin modifiers, signaling molecules, and transcription factors have been used to discover genes required for endothelial sprouting and arterialization. These screens are complemented by bioinformatics analyses to prioritize candidate genes.
How CRISPR Can Be Used to Study GO:0060982 coronary artery morphogenesis
Knockout
CRISPR knockout of genes such as SOX17, PIEZO1, or ARID2 in mice or endothelial cells can reveal their requirement for coronary artery morphogenesis. For example, Sox17 knockout mice exhibit defective coronary arteriogenesis, and Arid2 knockout leads to coronary artery developmental defects. Knockout studies are essential for establishing causality.
Point Mutation
CRISPR-mediated point mutations can model specific amino acid substitutions identified in patients with congenital coronary anomalies. For instance, introducing a point mutation in NOTCH1 or PIEZO1 can test whether the variant alters arterialization or mechanotransduction. These models are valuable for precision medicine.
Knock-in
Knock-in of reporter genes (e.g., GFP, tdTomato) into endogenous loci such as Sox17 or Cdh5 enables lineage tracing and live imaging of coronary artery development. Knock-in of human disease variants into mouse orthologs can also model congenital coronary anomalies.
Overexpression
Overexpression of pro-arteriogenic factors such as VEGFA or SOX17 using transgenic or viral vectors can enhance coronary artery growth and collateral formation. This approach is used to test therapeutic potential in models of myocardial ischemia. Overexpression of PIEZO1 may also promote vessel remodeling.
How EDITGENE Supports coronary artery morphogenesis Research
Researchers studying coronary artery morphogenesis-related genes often need to determine whether a candidate gene is causally involved in coronary artery development or whether its manipulation can enhance collateral formation. CRISPR-based genome editing provides a robust toolkit to interrogate gene function in endothelial cells, smooth muscle cells, and animal models. By combining knockout, point mutation, knock-in, and overexpression strategies, investigators can dissect the molecular mechanisms of coronary artery morphogenesis and validate therapeutic targets.
Contact EDITGENE today to design your custom CRISPR model for coronary artery morphogenesis research.
Frequently Asked Questions About coronary artery morphogenesis
What is GO:0060982 coronary artery morphogenesis?
GO:0060982 is a Gene Ontology biological process term that describes the generation and organization of the anatomical structures of coronary arteries, the blood vessels that supply blood to the heart muscle.
What genes are involved in coronary artery morphogenesis?
Key genes include SOX17, PIEZO1, ARID2 (BAF200), VEGFA, NOTCH1, DLL4, CXCR4, PDGFB, and TGFB1, among others.
Why is coronary artery morphogenesis important?
It is essential for establishing the coronary circulation that supplies oxygen to the heart; defects cause congenital coronary anomalies and myocardial ischemia.
What diseases are associated with defective coronary artery morphogenesis?
Congenital coronary artery anomalies, myocardial ischemia, heart failure, and increased risk of sudden cardiac death.
How is coronary artery morphogenesis studied?
Common methods include lineage tracing in mice, single-cell RNA sequencing, confocal imaging, and CRISPR-based functional screens.
What is the role of SOX17 in coronary artery morphogenesis?
SOX17 is a transcription factor that drives coronary arteriogenesis by activating arterial genes such as NOTCH1 and HEY2; its loss impairs coronary artery development.
How does PIEZO1 affect coronary artery development?
PIEZO1 is a mechanosensitive channel that senses shear stress and promotes vessel remodeling and arteriogenesis, influencing coronary artery stabilization.
Can CRISPR be used to study coronary artery morphogenesis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of genes like SOX17, PIEZO1, and ARID2 in coronary development.
What are coronary collaterals and how do they form?
Coronary collaterals are alternative vessels that form after cardiac injury; recent studies show they arise from progenitor cells sharing developmental programs with coronary artery morphogenesis.
What cell types contribute to coronary artery morphogenesis?
Endothelial cells, smooth muscle cells, pericytes, and epicardium-derived cells, with progenitors originating from sinus venosus endocardium and epicardium.
Conclusion
Coronary artery morphogenesis (GO:0060982) is a complex developmental process that establishes the coronary circulation essential for heart function. Research over the past decades has identified multiple progenitor sources, key transcriptional regulators such as SOX17, mechanosensitive pathways involving PIEZO1, and chromatin remodeling factors like BAF200. Defects in this process cause congenital coronary anomalies and contribute to ischemic heart disease. Emerging evidence links developmental programs to de novo collateral formation after injury, offering therapeutic opportunities. CRISPR-based models are powerful tools for dissecting the genetic basis of coronary artery morphogenesis and for validating new targets for cardiovascular disease.
References
- 1. Anderson RH et al.. 2022. The morphogenesis of abnormal coronary arteries in the congenitally malformed heart.. J Thorac Cardiovasc Surg 164(2):344-349 PMID: 34666912
- 2. Sharma B et al.. 2017. Coronary Artery Development: Progenitor Cells and Differentiation Pathways.. Annu Rev Physiol 79:1-19 PMID: 27959616
- 3. Ruiz-Villalba A et al.. 2024. Epicardium and Coronary Vessels.. Adv Exp Med Biol 1441:155-166 PMID: 38884710
- 4. Han M et al.. 2020. Sox17 and Coronary Arteriogenesis in Development.. Circ Res 127(11):1381-1383 PMID: 33151797
- 5. Chen K et al.. 2025. PIEZO1-activated donor lymphatic remodeling integrates with autologous lymphangiogenesis to enhance vein graft patency in mice.. Sci Transl Med 17(811):eads7438 PMID: 40802738
- 6. Cano E et al.. 2024. Intramyocardial Sprouting Tip Cells Specify Coronary Arterialization.. Circ Res 135(6):671-684 PMID: 39092506
- 7. Zhang M et al.. 2026. Tracing the origins of de novo coronary collateral formation in cardiac repair.. Science 393(6813):eady3027 PMID: 42623479
- 8. He L et al.. 2014. BAF200 is required for heart morphogenesis and coronary artery development.. PLoS One 9(10):e109493 PMID: 25299188
